STOCK TITAN

Decoy Therapeutics (DCOY) Revenue by Year

DCOY NASDAQ

Decoy Therapeutics Inc. does not report revenue for fiscal year 2025, so the figure is not reported on this page. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Decoy Therapeutics Inc. has filed alongside them.

FY2025 annual
Revenue N/A

Ticker history: SLRX became DCOY (Decoy Therapeutics Inc.) on . Earlier news and filings retain their original names and dates. View SLRX history.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DCOY Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
RevenueN/AN/AN/A$0-100.0%$1.8M-64.8%$5.2M+51.0%$3.5M+77.6%$2.0M+53.1%$1.3M+26.1%$1.0Mn/m$0

DCOY Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$228Kn/mN/AN/AN/A$0N/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Decoy Therapeutics Inc. financials

Frequently Asked Questions

Decoy Therapeutics Inc. does not report revenue for fiscal year 2025, so the figure is not reported on this page.

Decoy Therapeutics Inc. (DCOY) reported $228K in revenue in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Decoy Therapeutics Inc. (DCOY) reported on that line in every period on record.